X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 2026-01-30 | IP | International Paper Co /New/ | Paper Mills | 2 | P - Purchase | $40.11 | +75,000 | 75,000 | % | +$3,008,215 | |||||
| 2 | 2026-02-02 | CMTV | Community Bancorp /Vt | National Commercial Banks | 2 | P - Purchase | $31.38 | +3,000 | 19,565 | +18% | +$94,151 | |||||
| 2 D | 2025-11-05 | CCNE | Cnb Financial Corp/Pa | State Commercial Banks | 2 | P - Purchase | $25.88 | +2,075 | 187,296 | +1% | +$53,691 | |||||
| 4 | 2025-12-09 | NRIM | Northrim Bancorp Inc | Savings Institution, Federally Chartered | 4 | P - Purchase | $23.94 | +5,126 | 146,290 | +4% | +$122,722 | |||||
| 2 | 2026-01-27 | ALLY | Ally Financial Inc. | State Commercial Banks | 2 | P - Purchase | $42.16 | +35,366 | 571,717 | +7% | +$1,491,174 | |||||
| 2 D | 2026-01-26 | LOB | Live Oak Bancshares, Inc. | State Commercial Banks | 2 | P - Purchase | $36.23 | +3,595 | 9,292 | +63% | +$130,239 | |||||
| 2 | 2026-01-26 | ZIVO | Zivo Bioscience, Inc. | Biological Products, (No Diagnostic Substances) | 2 | P - Purchase | $8.54 | +23,418 | 299,099 | +8% | +$199,990 | |||||
| 5 | 2026-01-27 | SCISX | Ma Specialty Credit Income Fund | Closed-End Funds | 3 | P - Purchase | $24.93 | +493,366 | 5,739,117 | +9% | +$12,299,324 | |||||
| 5 | 2026-01-26 | TCGSX | Tcg Strategic Income Fund | Closed-End Funds | 2 | P - Purchase | $10.13 | +315,991 | 326,062 | >999% | +$3,200,000 | |||||
| 5 | 2026-01-23 | STEX | Streamex Corp. | Electromedical & Electrotherapeutic Apparatus | 3 | P - Purchase | $3.02 | +1,122,511 | 2,300,716 | +95% | +$3,385,298 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-29 | SHCO | Soho House & Co Inc. | Popstefanov Gjorgi | Dir | P - Purchase | $9.00 | +11,111,111 | 11,111,111 | New | +$99,999,999 | ||||||
| D | 2026-01-29 | LIFE | Ethos Technologies Inc. | Botha Roelof | Dir, 10% | P - Purchase | $19.00 | +260,525 | 260,525 | New | +$4,949,975 | |||||
2026-01-30 | IP | International Paper Co /New/ | Connor Christopher M | Dir | P - Purchase | $40.37 | +25,000 | 25,000 | New | +$1,009,250 | ||||||
2026-01-30 | ELUT | Elutia Inc. | Rakin Kevin | Dir, 10% | P - Purchase | $1.06 | +70,000 | 5,225,098 | +1% | +$74,200 | ||||||
2026-01-29 | CR | Crane Co | Pollino Jennifer | Dir | P - Purchase | $184.29 | +1,500 | 1,500 | New | +$276,435 | ||||||
2026-01-29 | CR | Crane Co | Lynch Susan D | Dir | P - Purchase | $182.22 | +150 | 220 | +214% | +$27,334 | ||||||
2026-01-29 | CR | Crane Co | Kapoor Sanjay | Dir | P - Purchase | $177.68 | +2,814 | 2,814 | New | +$499,992 | ||||||
2026-01-30 | CR | Crane Co | Mitchell Max H | COB, Pres, CEO | P - Purchase | $183.71 | +1,000 | 413,638 | 0% | +$183,710 | ||||||
2026-01-29 | CNXC | Concentrix Corp | Caldwell Christopher A | Pres, CEO | P - Purchase | $37.07 | +1,000 | 362,075 | 0% | +$37,070 | ||||||
| D | 2026-01-30 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO | P - Purchase | $0.89 | +28,100 | 375,520 | +8% | +$25,009 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-30 | ELUT | Elutia Inc. | Rakin Kevin | Dir, 10% | P - Purchase | $1.06 | +70,000 | 5,225,098 | +1% | +$74,200 | ||||||
| D | 2026-01-30 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO | P - Purchase | $0.89 | +28,100 | 375,520 | +8% | +$25,009 | |||||
| M | 2026-01-28 | EMPD | Empery Digital Inc. | Atg Capital Opportunities Fund LP | 10% | P - Purchase | $4.94 | +428,626 | 3,808,855 | +13% | +$2,115,728 | |||||
2026-01-28 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% | P - Purchase | $4.57 | +42,100 | 87,397 | +93% | +$192,502 | ||||||
| M | 2026-01-28 | THM | International Tower Hill Mines Ltd | Paulson & Co. Inc. | 10% | P - Purchase | $2.22 | +11,315,632 | 99,573,038 | +13% | +$25,120,703 | |||||
| M | 2026-01-28 | ELUT | Elutia Inc. | Neels Guido J | Dir | P - Purchase | $1.06 | +30,000 | 98,750 | +44% | +$31,800 | |||||
2026-01-27 | THM | International Tower Hill Mines Ltd | Electrum Global Holdings L.P. | 10% | P - Purchase | $2.22 | +3,153,153 | 31,918,825 | +11% | +$7,000,000 | ||||||
2026-01-28 | ANIX | Anixa Biosciences Inc | Baskies Arnold M | Dir | P - Purchase | $3.04 | +10,000 | 135,000 | +8% | +$30,400 | ||||||
2026-01-27 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.48 | +1,351,351 | 32,714,660 | +4% | +$1,999,999 | ||||||
2026-01-27 | THM | International Tower Hill Mines Ltd | Paulson & Co. Inc. | 10% | P - Purchase | $2.22 | +18,018,018 | 88,257,406 | +26% | +$40,000,000 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-29 | ALMU | Aeluma, Inc. | Tompkins Mark N. | 10% | S - Sale | $16.15 | -95,000 | 1,824,988 | -5% | -$1,534,585 | |||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Swayze Eric | EVP Research | S - Sale | $82.93 | -6,179 | 48,065 | -11% | -$512,446 | ||||||
| D | 2026-02-02 | ALKS | Alkermes Plc. | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $33.93 | -9,000 | 57,740 | -13% | -$305,385 | |||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $83.45 | -6,179 | 69,702 | -8% | -$515,630 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | O'Neil Patrick R. | EVP CLO, GC | S - Sale | $83.53 | -6,179 | 71,983 | -8% | -$516,153 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Monia Brett P | CEO | S - Sale | $82.72 | -62,970 | 283,927 | -18% | -$5,208,979 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Hougen Elizabeth L | EVP, Finance, CFO | S - Sale | $83.24 | -6,988 | 132,881 | -5% | -$581,702 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Birchler Brian | EVP, Corp, Development Ops | S - Sale | $83.03 | -6,179 | 66,247 | -9% | -$513,048 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale | $82.95 | -5,885 | 100,293 | -6% | -$488,141 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Baroldi Joseph | EVP, Chief Business Officer | S - Sale | $82.96 | -5,296 | 50,185 | -10% | -$439,364 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-30 | NYC | American Strategic Investment Co. | Schorsch Nicholas S | 10% | P - Purchase | $11.58 | +1,664 | 1,617,845 | 0% | +$19,269 | ||||||
| DM | 2026-01-29 | PSTL | Postal Realty Trust, Inc. | Garber Jeremy | Pres, Treasurer, Secretary | F - Tax | $17.92 | -12,025 | 243,365 | -5% | -$215,430 | |||||
| D | 2026-01-29 | PSTL | Postal Realty Trust, Inc. | Spodek Andrew | CEO, Dir, 10% | F - Tax | $17.67 | -9,485 | 943,922 | -1% | -$167,600 | |||||
| DM | 2026-01-29 | PSTL | Postal Realty Trust, Inc. | Brandwein Matt | EVP, Chief Accounting Officer | F - Tax | $17.90 | -4,126 | 121,569 | -3% | -$73,840 | |||||
| D | 2026-02-01 | PSTL | Postal Realty Trust, Inc. | Brandwein Matt | EVP, Chief Accounting Officer | A - Grant | $7.10 | +11,876 | 121,569 | +11% | +$84,370 | |||||
| M | 2026-01-29 | ALMU | Aeluma, Inc. | Tompkins Mark N. | 10% | S - Sale | $16.15 | -95,000 | 1,824,988 | -5% | -$1,534,585 | |||||
2026-01-31 | AWK | American Water Works Company, Inc. | Wikle Melissa K. | SVP, Chief Accounting Officer | F - Tax | $129.13 | -318 | 7,254 | -4% | -$41,063 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Swayze Eric | EVP Research | S - Sale | $82.93 | -6,179 | 48,065 | -11% | -$512,446 | ||||||
| D | 2026-02-02 | ALKS | Alkermes Plc. | Hopkinson Craig C. | EVP R, D, Chief Medical Office | M - OptEx | $19.34 | +5,000 | 57,740 | +9% | +$96,700 | |||||
| D | 2026-02-02 | ALKS | Alkermes Plc. | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $33.93 | -9,000 | 57,740 | -13% | -$305,385 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |